SMITH, ANDREW
 Distribuzione geografica
Continente #
NA - Nord America 6.797
EU - Europa 4.026
AS - Asia 1.121
SA - Sud America 17
AF - Africa 14
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.983
Nazione #
US - Stati Uniti d'America 6.695
IT - Italia 1.331
DE - Germania 687
IE - Irlanda 636
CN - Cina 619
SE - Svezia 478
HK - Hong Kong 203
AT - Austria 197
GB - Regno Unito 192
UA - Ucraina 145
VN - Vietnam 132
CA - Canada 100
FR - Francia 79
DK - Danimarca 78
FI - Finlandia 55
IN - India 46
TR - Turchia 35
RU - Federazione Russa 33
NL - Olanda 24
BE - Belgio 21
JP - Giappone 18
KR - Corea 14
TW - Taiwan 14
BR - Brasile 11
PL - Polonia 11
SG - Singapore 11
ES - Italia 10
GR - Grecia 9
NO - Norvegia 8
HR - Croazia 7
CH - Svizzera 6
EG - Egitto 6
RO - Romania 6
TH - Thailandia 6
AU - Australia 5
IL - Israele 5
PT - Portogallo 5
IR - Iran 4
PH - Filippine 4
BG - Bulgaria 3
MA - Marocco 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
KZ - Kazakistan 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
SC - Seychelles 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BT - Bhutan 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EU - Europa 1
ID - Indonesia 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 11.983
Città #
Ann Arbor 1.696
Dublin 622
Fairfield 582
Chandler 581
Frankfurt am Main 526
Milan 467
Wilmington 455
Ashburn 370
Woodbridge 365
Houston 311
Dearborn 301
New York 255
Seattle 242
Hong Kong 192
Vienna 190
Princeton 188
Cambridge 184
Jacksonville 145
Nanjing 128
Dong Ket 111
Shanghai 93
Lawrence 49
Beijing 45
Nanchang 45
Altamura 41
Rome 40
Falls Church 37
Lissone 37
Shenyang 36
San Diego 34
Guangzhou 33
Fremont 32
Helsinki 30
Hebei 29
Andover 28
Ottawa 26
Toronto 24
London 23
Los Angeles 21
Jiaxing 20
Boardman 18
Lachine 18
Changsha 17
Jinan 17
Pavia 17
Absecon 16
Brussels 16
Caronno Pertusella 16
Norwalk 16
Zhengzhou 16
Brescia 15
Monza 15
Ningbo 15
Pune 15
Hangzhou 14
Madison 14
Montréal 14
Tianjin 14
Kunming 13
San Giuliano Milanese 13
Cagliari 11
Edmonton 11
Bonndorf 10
Carate Brianza 10
Hefei 10
Kiev 10
Terni 10
Fermignano 9
Mountain View 9
Sacramento 9
Verona 9
Chicago 8
Napoli 8
Rho 8
Ripalta Cremasca 8
San Mateo 8
Sesto San Giovanni 8
Singapore 8
Washington 8
Birmingham 7
Daejeon 7
Guangdong 7
Legnano 7
Minamikasugaoka 7
Padova 7
Paullo 7
Taipei 7
Taizhou 7
Bayreuth 6
Bergamo 6
Kelty 6
Kilburn 6
Tokyo 6
Vrilissia 6
Wuhan 6
Atlanta 5
Bangkok 5
Castello di Brianza 5
Council Bluffs 5
Duncan 5
Totale 9.245
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 407
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 324
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 298
MALDI imaging in Fabry nephropathy: a multicenter study 288
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 255
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 251
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 248
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 246
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 246
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 242
The proteomic landscape of renal tumors 234
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 226
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 225
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 220
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 218
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 217
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 210
The putative role of MALDI-MSI in the study of Membranous Nephropathy 206
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 206
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 203
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 196
Proteomics for the study of new biomarkers in Fabry disease: State of the art 194
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 191
Tumor size, stage and grade alterations of urinary peptidome in RCC 191
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 184
Proteomics for the diagnosis of thyroid lesions: Preliminary report 183
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 179
Proteome analysis in thyroid pathology 176
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 170
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 164
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 159
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 157
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 154
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 153
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 146
Intraluminal proteome and peptidome of human urinary extracellular vesicles 145
The role of fine needle aspiration of orbital lesions: A case series 144
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 143
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 139
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 137
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 132
A molecular imaging approach to individuate tumour infiltrating lymphocytes 129
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 126
Machine learning approaches in MALDI-MSI: clinical applications 123
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 123
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 119
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 119
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 119
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 116
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 111
MALDI-MS imaging in the study of glomerulonephritis 110
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 108
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 103
The putative role of MALDI-MSI in the study of Membranous Nephropathy 100
The putative role of MALDI-MSI in the study of Membranous Nephropathy 96
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 92
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 89
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 88
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 82
α-1-antitrypsin detected by MALDI-Imaging in the study of glomerulonephritis: its relevance in chronic kidney disease progression 82
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 82
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 81
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 77
The Reed-Stanton press rig for the generation of reproducible fingermarks: Towards a standardised methodology for fingermark research 76
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 74
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 70
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 66
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 66
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 66
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 66
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 66
Determining the Age of a Latent Fingermark: Applying a Novel MALDI-MSI Methodology to an Age Old Forensic Conundrum 65
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 65
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 64
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 63
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 62
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 62
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 59
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 57
Precision medicine for Diabetic Nephropathy and Hypertensive Nephrosclerosis 57
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 56
MALDI mass spectrometry imaging in the analysis of primary glomerulonephritis 55
Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study) 53
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 50
Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients 49
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 49
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 48
Sample preparation considerations in MALDI-MS Imaging: What is your goal? 47
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 47
Correlazione di dati ottenuti con l’immagine istologica e microdissezione virtuale 47
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 45
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 44
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 43
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 41
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 41
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 39
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 36
Correlazione di dati ottenuti con l’immagine istologica e microdissezione virtuale 36
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 32
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 29
Totale 12.673
Categoria #
all - tutte 35.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019605 0 0 0 0 0 0 0 0 0 0 268 337
2019/20202.319 280 129 164 184 185 310 346 168 178 149 169 57
2020/20212.332 98 111 244 290 219 233 191 256 154 169 124 243
2021/20221.490 119 143 91 162 114 145 39 83 60 113 149 272
2022/20232.608 298 692 241 199 119 403 49 200 171 37 116 83
2023/20241.855 77 87 82 147 197 587 440 52 136 36 14 0
Totale 12.792